Healthcare
ABIONYX Pharma: Half-Year Review of the Liquidity Agreement Entered into with TP ICAP (Europe) SA
TOULOUSE, France, July 06, 2026--Regulatory News: Under the liquidity agreement covering the shares of ABIONYX Pharma (FR0012616852 – ABNX FP) entrusted to TP ICAP (Europe), the following assets were held in the liquidity account as of June 30, 2026:
About this update from Abionyx Pharma Sa
TOULOUSE, France, July 06, 2026--(BUSINESS WIRE)--Regulatory News: Under the liquidity agreement covering the shares of ABIONYX Pharma (FR0012616852 – ABNX FP) entrusted to TP ICAP (Europe), the following assets were held in the liquidity account as of June 30, 2026: During the first half of 2026, a total of: It should be noted that as of the half-yearly balance sheet dated December 31, 2025, the following assets were recorded in the cash account: It is noted that upon the establishment of the liquidity agreement, the following assets were made available: APPENDIX H1 2026